LYC Healthcare Berhad (KLSE:LYC)
Malaysia · Delayed Price · Currency is MYR 0.0150
+0.0050 (50.00%)
At close: Sep 1, 2026
LYC Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 136.17 | 134.19 | 155.52 | 128.99 | 92.28 | 64.6 | |
Revenue Growth | -8.13% | -13.71% | 20.57% | 39.78% | 42.86% | 144.56% |
Cost of Revenue | 66.92 | 61.5 | 86.55 | 60.72 | 50.7 | 32.41 |
Gross Profit | 69.25 | 72.7 | 68.97 | 68.27 | 41.58 | 32.19 |
Selling, General & Admin | 72.52 | 76.48 | 68.81 | 74.67 | 39.94 | 32.15 |
Other Operating Expenses | -5.12 | -4.58 | -4.17 | -6.01 | -0.15 | -7.63 |
Operating Expenses | 67.39 | 71.9 | 64.73 | 69.94 | 40.01 | 24.55 |
Operating Income | 1.86 | 0.8 | 4.24 | -1.67 | 1.57 | 7.64 |
Interest Expense | -9.99 | -10.91 | -10.71 | -9.47 | -11.22 | -8.76 |
Interest & Investment Income | 0.3 | 0.24 | 0.23 | 0.39 | 0.26 | 0.11 |
Earnings From Equity Investments | -0.04 | 0.03 | -0.19 | -1.4 | -2.23 | -0.51 |
Other Non Operating Income (Expenses) | - | -0 | -0.08 | -0.07 | -0.05 | -0.05 |
EBT Excluding Unusual Items | -7.87 | -9.85 | -6.5 | -12.22 | -11.67 | -1.58 |
Merger & Restructuring Charges | - | - | - | -0.07 | -0.19 | -0.29 |
Asset Writedown | - | - | -1.59 | -0.55 | - | - |
Other Unusual Items | - | - | - | - | - | 0.64 |
Pretax Income | -7.87 | -9.85 | -8.09 | -12.84 | -11.86 | -1.22 |
Income Tax Expense | 3.79 | 3.74 | 4.13 | 3.68 | 2.93 | 3.03 |
Earnings From Continuing Operations | -11.66 | -13.59 | -12.22 | -16.52 | -14.8 | -4.25 |
Net Income to Company | -11.66 | -13.59 | -12.22 | -16.52 | -14.8 | -4.25 |
Minority Interest in Earnings | -10.25 | -9.68 | -4.85 | -4.26 | -4.39 | -4.97 |
Net Income | -21.9 | -23.27 | -17.07 | -20.78 | -19.19 | -9.23 |
Net Income to Common | -21.9 | -23.27 | -17.07 | -20.78 | -19.19 | -9.23 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 704 | 715 | 715 | 550 | 436 |
Shares Outstanding (Diluted) | - | 704 | 715 | 715 | 550 | 436 |
Shares Change | - | -1.50% | - | 29.88% | 26.33% | 20.38% |
EPS (Basic) | - | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 |
EPS (Diluted) | - | -0.03 | -0.02 | -0.03 | -0.03 | -0.02 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 15.51 | 24.26 | 23.06 | 5.03 | 2.46 | -2.54 |
Free Cash Flow Per Share | - | 0.03 | 0.03 | 0.01 | 0.00 | -0.01 |
Gross Margin | 50.86% | 54.17% | 44.35% | 52.92% | 45.06% | 49.83% |
Operating Margin | 1.36% | 0.59% | 2.73% | -1.29% | 1.70% | 11.83% |
Profit Margin | -16.09% | -17.34% | -10.97% | -16.11% | -20.79% | -14.28% |
Free Cash Flow Margin | 11.39% | 18.08% | 14.82% | 3.90% | 2.67% | -3.93% |
EBITDA | 18.69 | 17.54 | 12.37 | 5.92 | 4.84 | 10.4 |
EBITDA Margin | 13.72% | 13.07% | 7.95% | 4.59% | 5.24% | 16.10% |
D&A For EBITDA | 16.83 | 16.75 | 8.13 | 7.59 | 3.27 | 2.76 |
EBIT | 1.86 | 0.8 | 4.24 | -1.67 | 1.57 | 7.64 |
EBIT Margin | 1.36% | 0.59% | 2.73% | -1.29% | 1.70% | 11.83% |